Cargando…
Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN
BACKGROUND: Transglutaminase 2 (TG2) and its phosphorylation have been consistently found to be upregulated in a number of cancer cell types. At the molecular level, TG2 has been associated with the activation of nuclear factor-kappa B (NF-κB), protein kinase B (PKB/Akt) and in the downregulation of...
Autores principales: | Wang, Yi, Ande, Sudharsana R, Mishra, Suresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492171/ https://www.ncbi.nlm.nih.gov/pubmed/22759359 http://dx.doi.org/10.1186/1471-2407-12-277 |
Ejemplares similares
-
Discovery and
Characterization of PROTACs Targeting
Tissue Transglutaminase (TG2)
por: Valdivia, Andres, et al.
Publicado: (2023) -
Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
por: Ebrahimi Samani, Sahar, et al.
Publicado: (2023) -
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
por: Martucciello, Stefania, et al.
Publicado: (2020) -
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011) -
Using TG1 and TG2's with cycle lengths > 32 s
por: Beetham, D
Publicado: (1983)